- Report
- January 2026
- 180 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- February 2026
- 250 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- May 2026
- 497 Pages
Global
From €5200EUR$5,850USD£4,513GBP
- Report
- August 2025
- 133 Pages
Global
From €3555EUR$3,999USD£3,085GBP
- Report
- July 2025
- 210 Pages
Global
From €4311EUR$4,850USD£3,741GBP
- Report
- July 2025
- 152 Pages
Africa, Middle East
From €3067EUR$3,450USD£2,661GBP
- Report
- July 2025
- 165 Pages
Europe
From €3067EUR$3,450USD£2,661GBP
- Report
- July 2025
- 165 Pages
Asia Pacific
From €3067EUR$3,450USD£2,661GBP
- Report
- July 2025
- 155 Pages
North America
From €3067EUR$3,450USD£2,661GBP
- Report
- October 2025
- 328 Pages
Global
From €4400EUR$4,950USD£3,819GBP
- Report
- June 2025
- 146 Pages
Global
From €3555EUR$3,999USD£3,085GBP
- Report
- July 2025
- 155 Pages
Global
From €4133EUR$4,650USD£3,587GBP
- Report
- October 2025
- 150 Pages
Global
From €5289EUR$5,950USD£4,590GBP
- Report
- October 2025
- 125 Pages
Global
From €5289EUR$5,950USD£4,590GBP
- Report
- November 2025
- 153 Pages
Global
From €4933EUR$5,550USD£4,281GBP
- Report
- October 2025
- 150 Pages
Global
From €5289EUR$5,950USD£4,590GBP
- Report
- May 2025
- 101 Pages
Global
From €5289EUR$5,950USD£4,590GBP
- Report
- May 2025
- 100 Pages
Global
From €5289EUR$5,950USD£4,590GBP
- Report
- March 2026
- 146 Pages
Global
From €3555EUR$3,999USD£3,085GBP
- Report
- January 2026
- 250 Pages
Global
From €3991EUR$4,490USD£3,464GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more